Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock

• Authors: Sri Harsha Patlolla, Mayo Clinic; Pranathi R. Sundaragiri, ChenMed; Wisit Cheungpasitporn, Mayo Clinic; Rajkumar Doshi, University of Nevada; Saraschandra Vallabhajosyula, Emory University
• Journal Title: Indian Heart Journal
• Volume: Volume 73, Number 5
• Publisher: Elsevier | 2021-07-17, Pages 565-571
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1016/j.ihj.2021.07.004
• Subjects: Health Sciences, Health Care Management; Health Sciences, Epidemiology; Health Sciences, Medicine and Surgery
• Keywords: Respiratory infections; Acute myocardial infarction; Cardiogenic shock; Outcomes research; Cardiac critical care

Abstract

Objective To evaluate the prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction (AMI-CS). Methods Using the National Inpatient Sample (2000–2017), this study identified adult (≥18 years) admitted with AMI-CS complicated by respiratory infections. Outcomes of interest included in-hospital mortality of AMI-CS admissions with and without respiratory infections, hospitalization costs, hospital length of stay, and discharge disposition. Temporal trends of prevalence, in-hospital mortality and cardiac procedures were evaluated. Results Among 557,974 AMI-CS admissions, concomitant respiratory infections were identified in 84,684 (15.2%). Temporal trends revealed a relatively stable trend in prevalence of respiratory infections over the 18-year period. Admissions with respiratory infections were on average older, less likely to be female, with greater comorbidity, had significantly higher rates of NSTEMI presentation, and acute non-cardiac organ failure compared to those without respiratory infections (all p < 0.001). These admissions received lower rates of coronary angiography (66.8% vs 69.4%, p < 0.001) and percutaneous coronary interventions (44.8% vs 49.5%, p < 0.001), with higher rates of mechanical circulatory support, pulmonary artery catheterization, and invasive mechanical ventilation compared to AMI-CS admissions without respiratory infections (all p < 0.001). The in-hospital mortality was lower among AMI-CS admissions with respiratory infections (31.6% vs 38.4%, adjusted OR 0.58 [95% CI 0.57–0.59], p < 0.001). Admissions with respiratory infections had longer lengths of hospital stay (127, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 vs 63, 4, 5, 6, 7, 8, 9, 10, 11 days, p < 0.001), higher hospitalization costs and less frequent discharges to home (27.1% vs 44.7%, p < 0.001). Conclusions Respiratory infections in AMI-CS admissions were associated with higher resource utilization but lower in-hospital mortality.